ARCHIVES

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | November 27, 2009

Download PDF Visit The Full Archive

Related Articles

Hugh Creech, Fox Chase Chemotherapy Pioneer, Dead at 92

January 31, 2003

DCCR Cancer Information Systems Program Renewed For Three More Years; Two Dropped, Two Added

September 1, 1978

DRCCA Board Gives Concept Approval To Nutrition Clinical Trials Which Could Total $52.5 Million

January 28, 1983

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

October 9, 2009

MicroRNA Biomarkers Linked To Early-Stage Prostate Cancer

February 24, 2012

Cytopathologists, NCI Recommend New Method For Pap Smear Reports

August 25, 1989